References
Healy D. The fluoxetine and suicide controversy: a review of the evidence. CNS Drugs 1994; 1: 223–31
Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990: 147: 207–10
Beasley CM, Dornseif VE, Postemworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ 1991: 303: 685–92
Beasley CM. Fluoxetine: no association with suicidality in obsessive-compulsive disorder. J Affect Disord 1992; 24: 1–10
Goldstein DJ, Rampey Jr AH, Potvin JH. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction. J Clin Psychiatry 1993; 54: 309–16
Wheadon DE, Rampey Jr AH, Thompson VL, et al. Lack of association between fluoxetine and suicidality in bulimia nervosa. J Clin Psychiatry 1992; 53: 235–41
PEM Report No 5 (fluoxetine). Drug Safety Research Unit, Southampton, September 1993.
Tollefson GD, Rampey AH, Beasley CM, et al. Absence of a relationship between adverse events and suicidality during pharmacotherapy for depression. J Clin Psychopharmacol 1994; 14: 163–9
Miller I, Bishop S, Norman W, et al. The modified Hamilton rating scale for depression: reliability and validity. Psychiatry Res 1985; 14: 131–42
Stanley B, Träskman-Bendz L, Stanley M. The suicide assessment scale: a scale evaluating change in suicidal behaviour. Psychopharmacol Bull 1986; 22: 200–5
Miller IW, Norman WH, Bishop SB, et al. The modified scale for suicidal ideation: reliability and validity. J Consult Clin Psychol 1986; 54: 724–5
Damluji NF, Ferguson JM. Paradox of the worsening of depressed symptomatology caused by antidepressants. J Clin Psychopharmacol 1988; 8: 347–9
Richelson E. Antidepressants and brain neurochemistry. Mayo Clin Proc 1990; 65: 1227–36
Rouillon F, Phillips R, Serrurier E, et al. Prophylactic efficacy of maprotilene on relapses of unipolar depression. L’Encephale 1989; 15: 527–34
Price J, Waller P, Wood S, et al. Safety of fluoxetine: comparison with fluvoxamine. Pharmacoepidemiol Drug Saf 1992; 1: 111–7
References
Healy D. The fluoxetine and suicide controversy: a review of the evidence. CNS Drugs 1994; 1: 223–31
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakielny, J., Healy, D. The Fluoxetine and Suicide Controversy. CNS Drugs 2, 252–254 (1994). https://doi.org/10.2165/00023210-199402030-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00023210-199402030-00008